MDT

88.65

+1.69%↑

VEEV

282.96

-1.55%↓

A

120.24

+1.92%↑

HQY

102.79

-1.67%↓

PHR.US

28.46

+0.21%↑

MDT

88.65

+1.69%↑

VEEV

282.96

-1.55%↓

A

120.24

+1.92%↑

HQY

102.79

-1.67%↓

PHR.US

28.46

+0.21%↑

MDT

88.65

+1.69%↑

VEEV

282.96

-1.55%↓

A

120.24

+1.92%↑

HQY

102.79

-1.67%↓

PHR.US

28.46

+0.21%↑

MDT

88.65

+1.69%↑

VEEV

282.96

-1.55%↓

A

120.24

+1.92%↑

HQY

102.79

-1.67%↓

PHR.US

28.46

+0.21%↑

MDT

88.65

+1.69%↑

VEEV

282.96

-1.55%↓

A

120.24

+1.92%↑

HQY

102.79

-1.67%↓

PHR.US

28.46

+0.21%↑

Search

STAAR Surgical Co

Uždarymo kaina

SektoriusSveikatos priežiūra

16.99 1.13

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

16.24

Max

17.7

Pagrindiniai rodikliai

By Trading Economics

Pajamos

-20M

-54M

Pardavimai

-6.4M

43M

P/E

Sektoriaus vid.

55.443

40.527

Pelnas, tenkantis vienai akcijai

-1.005

Pelno marža

-127.289

Darbuotojai

1,157

EBITDA

-43M

-71M

Rekomendacijos

By TipRanks

Rekomendacijos

Neutralu

12 mėnesių prognozė

+14.06% upside

Dividendai

By Dow Jones

Kitas uždarbis

2025-08-06

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

38M

831M

Ankstesnė atidarymo kaina

15.86

Ankstesnė uždarymo kaina

16.99

Naujienos nuotaikos

By Acuity

25%

75%

143 / 380 reitingas Healthcare

Techninis įvertinimas

By Trading Central

Pasitikėjimas

Strong Bullish Evidence

STAAR Surgical Co Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2025-07-01 23:09; UTC

Uždarbis

Constellation Brands 1Q Profit, Sales Decline Amid Softer Consumer Demand -- Update

2025-07-01 19:16; UTC

Įsigijimai, susijungimai, perėmimai

Sabadell Seeks Shareholder Approval of Nearly $4 Billion Sale of U.K. Unit to Santander

2025-07-01 23:47; UTC

Rinkos pokalbiai

Nikkei May Fall Amid U.S. Tariff Uncertainty -- Market Talk

2025-07-01 23:41; UTC

Rinkos pokalbiai

Gold Steady, Underpinned by U.S. Fiscal-Deficit Concerns -- Market Talk

2025-07-01 22:23; UTC

Įsigijimai, susijungimai, perėmimai

James Hardie: Deal Represents Implied Value of $8.4 Billion

2025-07-01 22:23; UTC

Įsigijimai, susijungimai, perėmimai

James Hardie: Cash and Stock Deal Implies $54.18 Per AZEK Share

2025-07-01 22:21; UTC

Įsigijimai, susijungimai, perėmimai

James Hardie Completes Acquisition of AZEK

2025-07-01 20:50; UTC

Rinkos pokalbiai

Health Care Roundup: Market Talk

2025-07-01 20:50; UTC

Rinkos pokalbiai

Basic Materials Roundup: Market Talk

2025-07-01 20:24; UTC

Uždarbis

Constellation Brands Earnings Miss as Consumers Cool on Alcohol -- Barrons.com

2025-07-01 19:55; UTC

Rinkos pokalbiai

Oil Futures Resume Cautious Rally -- Market Talk

2025-07-01 19:27; UTC

Rinkos pokalbiai

U.S. Natural Gas Futures Lose More Ground -- Market Talk

2025-07-01 19:12; UTC

Rinkos pokalbiai

Dollar Little Changed as Tax-And-Spending Bill Advances -- Market Talk

2025-07-01 19:01; UTC

Įsigijimai, susijungimai, perėmimai

Sabadell Seeks Shareholder Approval of Nearly $4B Sale of U.K. Unit to Santander

2025-07-01 18:41; UTC

Įsigijimai, susijungimai, perėmimai

How DexCom, Insulet, and Amedisys Might Be Affected by Medicare Cuts -- Barrons.com

2025-07-01 18:33; UTC

Rinkos pokalbiai

Market Talk Roundup: Latest on U.S. Politics

2025-07-01 18:33; UTC

Rinkos pokalbiai

Gold Gains as Investors Look Ahead on Budget Bill -- Market Talk

2025-07-01 18:32; UTC

Rinkos pokalbiai

Mexico Manufacturing PMIs Remain Weak in June -- Market Talk

2025-07-01 18:22; UTC

Rinkos pokalbiai

Remittances to Mexico Down in May -- Market Talk

2025-07-01 17:45; UTC

Rinkos pokalbiai

Seasonal Demand Supports Further Oil Gains -- Market Talk

2025-07-01 17:01; UTC

Įsigijimai, susijungimai, perėmimai

Danone Completed Acquisition of Majority Stake in Kate Farms

2025-07-01 16:55; UTC

Uždarbis

10 European Dividend Stocks That Could Beat Their U.S. Counterparts -- Barrons.com

2025-07-01 16:27; UTC

Rinkos pokalbiai

Trade Concerns Ease in Bank of Mexico Survey -- Market Talk

2025-07-01 16:25; UTC

Rinkos pokalbiai
Įsigijimai, susijungimai, perėmimai

Home Depot's GMS Buy Unlocks New Vertical Adjacent to SRS -- Market Talk

2025-07-01 16:20; UTC

Rinkos pokalbiai

Health Care Roundup: Market Talk

2025-07-01 15:48; UTC

Rinkos pokalbiai
Įsigijimai, susijungimai, perėmimai

Home Depot's Offer for GMS Unlikely to Be Beat -- Market Talk

2025-07-01 15:46; UTC

Rinkos pokalbiai

Global Equities Roundup: Market Talk

2025-07-01 15:46; UTC

Rinkos pokalbiai

Amazon Seen With Improved Logistics Ahead of Longer Prime Day -- Market Talk

2025-07-01 14:54; UTC

Rinkos pokalbiai

Thales Expected to Stick to This Year's Sales Guidance -- Market Talk

2025-07-01 14:49; UTC

Rinkos pokalbiai

Platinum Prices Extend Rally on China Demand, Supply Worries -- Market Talk

Akcijų palyginimas

Kainos pokytis

STAAR Surgical Co Prognozė

Kainos tikslas

By TipRanks

14.06% į viršų

12 mėnesių prognozė

Vidutinis 19.14 USD  14.06%

Aukščiausias 27 USD

Žemiausias 13 USD

Remiantis 9 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines STAAR Surgical Co kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Neutralu

9 ratings

2

Pirkti

6

Laikyti

1

Parduoti

Techninis įvertinimas

By Trading Central

18.604 / 20.07Palaikymas ir pasipriešinimas

Trumpalaikis periodas

Strong Bullish Evidence

Vidutinės trukmės periodas

Very Strong Bullish Evidence

Ilgalaikis periodas

No Evidence

Rinkos nuotaikos

By Acuity

143 / 380 reitingas Sveikatos priežiūra

Naujienos nuotaikos

Labai stiprus bulių rinkos įrodymas

Svyravimai

Žemiau vidurkio

Naujienų apimtis (RCV)

Žemiau vidurkio

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

$

Apie bendrovę STAAR Surgical Co

STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia. It markets its products to health care providers, including ophthalmic surgeons, vision and surgical centers, hospitals, government facilities, and distributors, as well as products are primarily used by ophthalmologists. The company sells its products directly through its sales representatives in the United States, Japan, Germany, Spain, Canada, the United Kingdom, and Singapore, as well as through own representatives and independent distributors in China, Korea, India, France, Benelux, Italy, and internationally. STAAR Surgical Company was incorporated in 1982 and is headquartered in Lake Forest, California.